Gemmus Pharma Inc.
Repurposed drug for Influenza treatment
Gemmus Pharma Inc. is a privately held company incorporated in August 2007 to develop host-targeted treatments for moderate to life-threatening influenza infections. Gemmus' lead candidate was identified at a major pharmaceutical company and is a repurposed drug. Gemmus has submitted a pre-IND package to the FDA and has a defined development plan to obtain an IND.